ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

New Prostate Cancer Detection Group to Study Ultrasound

March 6, 1987

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

Governors Hear Pitch For State Cancer Control Increased Effort

August 3, 1979

NCI-Approved CTEP Trials For The Month of July

July 27, 2012

NCI forms pediatric central IRB.

July 30, 2004